Welcome to our dedicated page for Kraig Biocraft Laboratories In news (Ticker: KBLB), a resource for investors and traders seeking the latest updates and insights on Kraig Biocraft Laboratories In stock.
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) regularly issues detailed news releases about its work in recombinant spider silk and bioengineered fibers. The company describes itself as a world leader in spider silk technology and uses its news flow to report on production milestones, facility expansions, scientific progress, and commercial engagements.
News items often highlight advances in the company’s BAM-1 and BAM-1 Alpha hybrid silkworm lines, including selective breeding achievements that increase cocoon shell weight, throughput, and production efficiency. Kraig Biocraft Laboratories also reports on the launch and completion of spider silk production cycles, the deployment of BAM-1 Alpha as its primary production hybrid, and the integration of diapause egg management into its rearing operations.
Another recurring theme in KBLB news is the build-out of production infrastructure in Southeast Asia. Releases cover topics such as taking possession of additional silkworm rearing centers, relocating facilities to protected highlands, and maintaining multiple, parallel production sites to support scalability and resilience. The company also reports on securing usage rights to government-owned mulberry gardens and taking control of mulberry fields dedicated to its operations, emphasizing feedstock security and vertical coordination.
Investors and observers can also find updates on commercial and research developments, including pilot programs with a globally recognized performance sports apparel brand and announcements about scientific leadership and breakthroughs in advanced fibers and bioengineered materials. Together, these news items provide an ongoing view into Kraig Biocraft Laboratories’ efforts to expand spider silk production capacity, refine its technology, and pursue high-value applications in performance textiles, technical apparel, and other markets.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Kraig Biocraft Laboratories (OTCQB: KBLB) announced its preparation for a response to the U.S. Air Force under the Defense Production Act Investments program. This initiative aims to bolster U.S. bio-industrial manufacturing capabilities, specifically targeting materials like spider silk. Kraig Labs is set to submit its detailed response by April 19, 2023. While this does not guarantee funding or a proposal request, it signifies the growing interest in biomanufactured materials. COO Jon Rice expressed optimism about Kraig's role in enhancing domestic biomanufacturing and updating the DoD on its advancements.
Kraig Biocraft Laboratories (OTCQB: KBLB) has announced the creation of two senior-level genetic engineering positions within its research and development team in the U.S. This expansion aims to enhance the team's capabilities, accelerating the development of spider silk technologies. The company expects these new roles will significantly increase research throughput, allowing for faster transition from concept to production for various spider silk protein designs. COO Jon Rice emphasized the potential for advancing new materials and transgenics in this exciting phase for the company.
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) announced the delivery of the first two hybrid-cross Dragon Silk™ strains to its production partner in Vietnam. This development addresses key challenges in large-scale production, enhancing the robustness of silkworms. The new strains combine the mechanical performance of Dragon Silk with local silkworm traits, increasing cocoon size and resilience. Kraig Labs is also pursuing a four-line hybrid-cross program to further improve yields. COO Jon Rice highlighted the progress in overcoming production scaling challenges, signaling potential increases in production capacity and efficiency.